SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-092772
Filing Date
2024-08-07
Accepted
2024-08-07 16:08:11
Documents
65
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q allk-20240630.htm   iXBRL 10-Q 1518424
2 EX-10.1 allk-ex10_1.htm EX-10.1 33721
3 EX-31.1 allk-ex31_1.htm EX-31.1 16620
4 EX-31.2 allk-ex31_2.htm EX-31.2 16643
5 EX-32.1 allk-ex32_1.htm EX-32.1 8925
6 EX-32.2 allk-ex32_2.htm EX-32.2 8946
  Complete submission text file 0000950170-24-092772.txt   6845431

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT allk-20240630.xsd EX-101.SCH 899038
68 EXTRACTED XBRL INSTANCE DOCUMENT allk-20240630_htm.xml XML 1298144
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38582 | Film No.: 241183705
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)